Besides, both p53 and cyt c were markedly upregulated and colocalized in SHK-treated cells (at the dose of 2.5 μg/mL) as examined by immunofluorescence analyses (Figure 4(c)), illustrating the apoptotic pathways in A549 lung cancer cells. The gene discussed is TP53; the disease is lung carcinoma.